Highlights
NASDAQ: PATH       Uipath Inc Cl A
Last Price Today's Change   Day's Range   Trading Volume
54.35   +0.45 (0.83%)  53.915 - 55.325  4,502,841

Overview

 
Avg Volume (4 weeks):6,783,133
4 Weeks Range:52.69 - 65.85
4 Weeks Price Volatility (%):
12.61%
52 Weeks Range:52.69 - 90.00
52 Weeks Price Volatility (%):
4.45%
Average Price Target: 17.00
Price Target Upside/Downside: -37.35

Headlines



No recent Headlines for this stock.


Business Background

NuPathe, Inc. develops therapeutics for diseases of the central nervous system including neurological and psychiatric disorders. The Companys products are NP201 for the continuous symptomatic treatment of Parkinson's disease and NP202 for the long-term treatment of schizophrenia and bipolar disorder. The Company completed a pivotal Phase III clinical trial for Zelrix, an active, single-use transdermal sumatriptan patch for the treatment of acute migraine.

  Be the first to like this.
 
sammofee ada potential
21/08/2021 9:40 PM


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1845  2519  191  6721 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SDC 6.855+0.855 
 AAPL 146.795-1.995 
 WORK 45.20+0.04 
 IPHA 8.16+2.41 
 PLTR 28.789+0.159 
 LCID 23.224+2.054 
 F 13.61+0.21 
 AMC 45.39-0.651 
 VALE 16.255-0.465 
 BAC 40.37-0.08